Oncodesign SA (ALONC):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7557)
◆英語タイトル:Oncodesign SA (ALONC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7557
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Oncodesign SA (Oncodesign) is a biopharmaceutical company, specializing in precision medicine offers drug discovery and pharmacological evaluation services for cancer. Its service offerings include integrated drug discovery; metabolic and pharmacokinetic characteristics of chemical and biological substances; assessment and validation of anti-cancer therapies, biomarker development and monitoring, translational biomarkers, and biodecontamination services. Oncodesign’s technological platforms includes PREDICT, a conventional in vitro and in vivo pharmacology platform; Chi-Mice that concentrates on developing in vivo chimeric experimental models; Pharm’Image, a multi-modal and non-invasive pharmaco-imaging platform; and Nanocyclix, for the synthesis and optimization of novel compounds used for diagnostic and therapeutic purpose, among others. The company has its operations in Europe and the Americas. Oncodesign is headquartered in Dijon, France.

Oncodesign SA (ALONC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oncodesign SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oncodesign SA, Medical Devices Deals, 2012 to YTD 2018 10
Oncodesign SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Oncodesign SA, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Oncodesign Acquires Service Businesses from Bertin Pharma 12
Oncodesign Acquires Francois Hyafil Research Centre from GlaxoSmithKline 13
Partnerships 14
Ipsen Partners with Oncodesign 14
Oncodesign Enters into Agreement with Bristol-Myers Squibb 15
Oncodesign Enters Into Research Agreement With Sanofi 16
Oncodesign And Laboratory For Neurobiology and Gene Therapy Enter Into Research Agreement With Ipsen For Parkinson’s Disease 17
Sanofi Enters Into Research Agreement With Oncodesign 19
Oncodesign Enters into Research Agreement with Ipsen 20
Licensing Agreements 21
UCB Exercises Option for Licensing Agreement with Oncodesign 21
Equity Offering 22
Oncodesign Raises Funds through Private Placement of Shares 22
Oncodesign Raises USD17.8 Million in IPO 23
Oncodesign SA – Key Competitors 24
Oncodesign SA – Key Employees 25
Oncodesign SA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Sep 26, 2018: Oncodesign: 1st Half 2018 Results 27
Jul 24, 2018: ONCODESIGN: Very strong revenue growth of 58% to €9.2 million in the first half of 2018 29
Apr 11, 2018: Oncodesign: 2017 annual results 30
Jan 30, 2018: Oncodesign Reports Total Sales Of €14.41m In 2017 32
Sep 19, 2017: Oncodesign: First-Half 2017 Results 33
Jul 20, 2017: Oncodesign: Stable Revenue in the First Half of 2017 35
Mar 30, 2017: ONCODESIGN: Business update and FY 2016 results 36
Jan 31, 2017: Oncodesign reports its FY 2016 revenue 38
Corporate Communications 40
Apr 23, 2018: Oncodesign Announces the Nomination of Arnaud Lafforgue as Chief Financial Officer 40
Government and Public Interest 41
Feb 07, 2017: Oncodesign’s OncoSNIPE collaborative programme receives €7.7 million in support from the “Investments for the Future Programme” operated by Bpifrance 41
Product News 42
Dec 05, 2017: Oncodesign reports positive results for its MNK1/2 program 42
Other Significant Developments 43
Oct 18, 2017: OncoSNIPE Artificial Intelligence Project Officially Launched 43
Oct 18, 2017: Oncodesign: OncoSNIPE artificial intelligence project officially launched 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Oncodesign SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oncodesign SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oncodesign SA, Deals By Therapy Area, 2012 to YTD 2018 9
Oncodesign SA, Medical Devices Deals, 2012 to YTD 2018 10
Oncodesign SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Oncodesign Acquires Service Businesses from Bertin Pharma 12
Oncodesign Acquires Francois Hyafil Research Centre from GlaxoSmithKline 13
Ipsen Partners with Oncodesign 14
Oncodesign Enters into Agreement with Bristol-Myers Squibb 15
Oncodesign Enters Into Research Agreement With Sanofi 16
Oncodesign And Laboratory For Neurobiology and Gene Therapy Enter Into Research Agreement With Ipsen For Parkinson's Disease 17
Sanofi Enters Into Research Agreement With Oncodesign 19
Oncodesign Enters into Research Agreement with Ipsen 20
UCB Exercises Option for Licensing Agreement with Oncodesign 21
Oncodesign Raises Funds through Private Placement of Shares 22
Oncodesign Raises USD17.8 Million in IPO 23
Oncodesign SA, Key Competitors 24
Oncodesign SA, Key Employees 25
Oncodesign SA, Other Locations 26

List of Figures
Oncodesign SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oncodesign SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oncodesign SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oncodesign SA, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Oncodesign SA (ALONC):製薬・医療:M&Aディール及び事業提携情報(Oncodesign SA (ALONC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆